Rapid Update 4 – October 2016: Statins: Review and interpretation of the evidence for efficacy and safety

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Lipid-lowering in people with intermediate-risk without cardiovascular disease: results from the HOPE-3 trial (Jul-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Blood pressure lowering in people with intermediate risk without cardiovascular disease: antihypertensive results from the HOPE-3 trial (Jul-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Lipid Modification: Does low-density lipoprotein cholesterol matter in older people? (Jun-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Cardiovascular disease: Meta-analysis finds that gains in all-cause survival with statin treatment are small (Nov-15)